Thomas A. Mccourt

Insider Reports History

Location
Boston, MA
Signature
/s/ Amir Vitale, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas A. Mccourt:

Form 4 holding Director

PLIANT THERAPEUTICS, INC.

Security class
Common Stock (Right to Buy)
Shares / value
30,000
Estimated value
$55,669
Report date
05 Jun 2025
Price
$2.08
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ACCELERON PHARMA INC

Security class
Common Stock
Shares / value
0
Estimated value
Report date
19 Nov 2021
Price
$29.37
Ownership
Direct
Form 4 holding Director

ACCELERON PHARMA INC

Security class
Option to Purchase Common Stock
Shares / value
0
Estimated value
Report date
19 Nov 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Thomas A. Mccourt

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .